The field of mitral valve disease diagnosis and management is rapidly changing. New
understanding of disease pathology and progression, with improvements in and increased …

Growing clinical data support the use of transcatheter therapies for significant mitral valve
disease. Currently, edge-to-edge repair is the transcatheter treatment of choice, but many …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Aims We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR)
for patients with degenerated bioprostheses [valve-in-valve (ViV)], failed annuloplasty rings …

Mitral regurgitation (MR) is a complex valve lesion that can pose significant management
challenges. This expert consensus decision pathway emphasizes that recognition of MR …

Background Mitral regurgitation is the most common valve disease worldwide but whether
the community-wide prevalence, poor patient outcomes, and low rates of surgical treatment …

Background: Symptomatic mitral regurgitation (MR) is associated with high morbidity and
mortality that can be ameliorated by surgical valve repair or replacement. Despite this, many …

Use of transcatheter mitral valve replacement (TMVR) using transcatheter aortic valves in
clinical practice is limited to patients with failing bioprostheses and rings or mitral valve …